The impact of cardiovascular risk factors on cardiac structure and function: Insights from the UK Biobank imaging enhancement study

Aims The UK Biobank is a large-scale population-based study utilising cardiovascular magnetic resonance (CMR) to generate measurements of atrial and ventricular structure and function. This study aimed to quantify the association between modifiable cardiovascular risk factors and cardiac morphology and function in individuals without known cardiovascular disease. Methods Age, sex, ethnicity (non-modifiable) and systolic blood pressure, diastolic blood pressure, smoking status, exercise, body mass index (BMI), high cholesterol, diabetes, alcohol intake (modifiable) were considered important cardiovascular risk factors. Multivariable regression models were built to ascertain the association of risk factors on left ventricular (LV), right ventricular (RV), left atrial (LA) and right atrial (RA) CMR parameters. Results 4,651 participants were included in the analysis. All modifiable risk factors had significant effects on differing atrial and ventricular parameters. BMI was the modifiable risk factor most consistently associated with subclinical changes to CMR parameters, particularly in relation to higher LV mass (+8.3% per SD [4.3 kg/m2], 95% CI: 7.6 to 8.9%), LV (EDV: +4.8% per SD, 95% CI: 4.2 to 5.4%); ESV: +4.4% per SD, 95% CI: 3.5 to 5.3%), RV (EDV: +5.3% per SD, 95% CI: 4.7 to 5.9%; ESV: +5.4% per SD, 95% CI: 4.5 to 6.4%) and LA maximal (+8.6% per SD, 95% CI: 7.4 to 9.7%) volumes. Increases in SBP were associated with higher LV mass (+6.8% per SD, 95% CI: 5.9 to 7.7%), LV (EDV: +4.5% per SD, 95% CI: 3.6 to 5.4%; ESV: +2.0% per SD, 95% CI: 0.8 to 3.3%) volumes. The presence of diabetes or high cholesterol resulted in smaller volumes and lower ejection fractions. Conclusions Modifiable risk factors are associated with subclinical alterations in structure and function in all four cardiac chambers. BMI and systolic blood pressure are the most important modifiable risk factors affecting CMR parameters known to be linked to adverse outcomes.

[1]  J. Polak,et al.  Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. , 1983, Journal of the American College of Cardiology.

[2]  H. Keen,et al.  MYOCARDIAL ISCHÆMIA, RISK FACTORS AND DEATH FROM CORONARY HEART-DISEASE , 1977, The Lancet.

[3]  Mary A Whooley,et al.  Prognostic value of left ventricular end-systolic volume index as a predictor of heart failure hospitalization in stable coronary artery disease: data from the Heart and Soul Study. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[4]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[5]  H. S. Klopfenstein,et al.  M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). , 2001, The American journal of cardiology.

[6]  J. Salonen,et al.  Left atrium size and the risk of cardiovascular death in middle-aged men. , 2005, Archives of internal medicine.

[7]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[8]  M. Gladwin,et al.  Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. , 2006, Circulation.

[9]  The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. , 1988, Journal of clinical epidemiology.

[10]  M. Vandenheuvel,et al.  right ventricular function and failure , 2014 .

[11]  P. Matthews,et al.  UK Biobank’s cardiovascular magnetic resonance protocol , 2015, Journal of Cardiovascular Magnetic Resonance.

[12]  Nathan D. Wong,et al.  Epidemiological studies of CHD and the evolution of preventive cardiology , 2014, Nature Reviews Cardiology.

[13]  G. Mancia,et al.  The Pamela Study: Main Findings and Perspectives , 2013, Current Hypertension Reports.

[14]  S. Kim,et al.  Association of cardiovascular disease risk factors with left ventricular mass, biventricular function, and the presence of silent myocardial infarction on cardiac MRI in an asymptomatic population , 2016, The International Journal of Cardiovascular Imaging.

[15]  Kieran Clarke,et al.  Journal of Cardiovascular Magnetic Resonance Determinants of Left Ventricular Mass in Obesity; a Cardiovascular Magnetic Resonance Study , 2022 .

[16]  B. Lorell,et al.  Left ventricular hypertrophy: pathogenesis, detection, and prognosis. , 2000, Circulation.

[17]  Ayan R Patel,et al.  Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. , 2011, JACC. Cardiovascular imaging.

[18]  Stefan K. Piechnik,et al.  Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort , 2017, Journal of Cardiovascular Magnetic Resonance.

[19]  B. Pluim,et al.  Left Ventricular Hypertrophy , 2020, Developments in Cardiovascular Medicine.

[20]  T. Cook,et al.  The impact of gender on cardiovascular system calcification in very elderly patients with severe aortic stenosis , 2015, The International Journal of Cardiovascular Imaging.

[21]  C. Coats.  Smoking and Tobacco Use , 2010 .

[22]  M. Frigerio,et al.  Drugs for left ventricular remodeling in heart failure. , 2005, The American journal of cardiology.

[23]  D. Bluemke,et al.  Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis. , 2006, Journal of the American College of Cardiology.

[24]  D. Bluemke,et al.  Relation of cardiovascular risk factors to right ventricular structure and function as determined by magnetic resonance imaging (results from the multi-ethnic study of atherosclerosis). , 2010, The American journal of cardiology.

[25]  S. Petersen,et al.  See Clinical Perspective , 2022 .

[26]  G. Thorgeirsson,et al.  Prevalence of coronary heart disease in Icelandic men 1968-1986. The Reykjavik Study. , 1993, European heart journal.

[27]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.

[28]  D. Berman,et al.  Variable spectrum and prognostic implications of left and right ventricular ejection fractions in patients with and without clinical heart failure after acute myocardial infarction. , 1986, The American journal of cardiology.

[29]  G. Lip,et al.  Atrial fibrillation—the growing epidemic , 2007, Heart.

[30]  B. Hoit,et al.  Left atrial size and function: role in prognosis. , 2014, Journal of the American College of Cardiology.

[31]  P. Matthews,et al.  Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches , 2013, Journal of Cardiovascular Magnetic Resonance.

[32]  L. Solberg,et al.  Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex. , 1968, Laboratory investigation; a journal of technical methods and pathology.

[33]  S. Kim,et al.  Erratum to: Association of cardiovascular disease risk factors with left ventricular mass, biventricular function, and the presence of silent myocardial infarction on cardiac MRI in an asymptomatic population , 2016, The International Journal of Cardiovascular Imaging.

[34]  J. Ghali,et al.  The Prognostic Role of Left Ventricular Hypertrophy in Patients with or without Coronary Artery Disease , 1992, Annals of Internal Medicine.

[35]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[36]  Daniel W. Jones,et al.  Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. , 2005, Ethnicity & disease.

[37]  J. Gardin,et al.  Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. , 1995, Circulation.

[38]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[39]  Salim Yusuf,et al.  The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. , 2009, American heart journal.

[40]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[41]  S. Gidding,et al.  Preventing Heart Disease in the 21st Century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study , 2008, Circulation.

[42]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[43]  D. Bluemke,et al.  Normal values for cardiovascular magnetic resonance in adults and children , 2015, Journal of Cardiovascular Magnetic Resonance.

[44]  H. Keen,et al.  Myocardial ischaemia, risk factors and death from coronary heart-disease. , 1977, Lancet.

[45]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .

[46]  A. Klein,et al.  Right atrial volume index in chronic systolic heart failure and prognosis. , 2009, JACC. Cardiovascular imaging.

[47]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.